![](/img/cover-not-exists.png)
6534 POSTER Elevated levels of thioredoxin (Trx) in serum correlate with poor outcome in docetaxel (doc)/cisplatin (cis)-treated stage IV non-small-cell lung cancer (NSCLC) patients (pts)
Molina, M.A., Camps, C., DelasPeñas, R., Alonso, G., Lopez-Vivanco, G., Provencio, M., González-Larriba, J.L., Salazar, F., Sánchez, J.J., Rosell, R.Volume:
5
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(07)71362-9
Date:
September, 2007
File:
PDF, 60 KB
english, 2007